Head-to-head · WeighScore
CoreAge Rx vs Rivo Health
By GLP-1 ScorecardUpdated
Score comparison
CoreAge Rx has the higher recorded score — 89.5/100 to 71.7/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | Rivo Health |
|---|---|---|
| WeighScore | 89.5/100 | 71.7/100 |
| Grade | B+ | C |
| Site position | #1 | #100 |
| Semaglutide | Product page from $79/mo; navigation $99. Confirm selected quote. | $149/mo advertised starting rate on annual plan (compounded; confirm selected charge and renewal) |
| Tirzepatide | From $129/mo advertised; confirm selected charge, supply and renewal. | $199/mo advertised starting rate on annual plan (compounded; confirm selected charge and renewal) |
| Coverage | US only; therapy-specific state restrictions apply | State eligibility unverified; confirm prescribing and dispensing availability for your address |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Yes |
Site position #1 · B+
Strengths
- Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
- Advertises the same price across doses and no membership fee
- Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy
What to consider
- Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
- FAQ no-rebill and payment-timing statements differ from the subscription and order policy
- FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
- Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
- Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Site position #100 · C
Strengths
- Advertises semaglutide and tirzepatide injection and oral options
- Starting-price cards disclose an annual-plan condition
- Advertises provider visits, nutrition support and dietitian access
- Current public pages name Rivo Health, Inc. and a Rimo Health clinical network
What to consider
- The $149/$199 labels are annual-plan starting rates; first charge, total obligation and renewal remain unverified
- The selected cancellation and refund agreement has not been verified
- Exact treating practice, dispensing branch and individual state/license eligibility remain unverified
- Bundled service frequency, lab costs, supplied quantity and extra charges need selected-plan confirmation
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.